Mannkind (MNKD) Cash & Current Investments (2010 - 2026)
Mannkind (MNKD) reported Cash & Current Investments of $134.6 million for Q1 2026, down 26.15% year-over-year from $182.3 million in Q1 2025, and down 21.44% on a QoQ basis from $171.3 million in Q4 2025.
Mannkind (MNKD) has 17 years of Cash & Current Investments data on file, last reported at $134.6 million in Q1 2026.
- Quarterly Cash & Current Investments fell 26.15% year-over-year to $134.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $134.6 million (down 26.15% YoY) and the FY2025 annual result came in at $171.3 million, down 13.46% from the prior year.
- Cash & Current Investments slipped to $134.6 million in Q1 2026 per MNKD's latest filing, from $171.3 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $300.7 million in Q1 2024 and bottomed at $134.6 million in Q1 2026.
- The 5-year median for Cash & Current Investments is $171.3 million (2025), against an average of $195.6 million.
- The widest annual swing landed in 2022, when Cash & Current Investments sank 41.34%; it then jumped 81.01% in 2024.
- Tracing MNKD's Cash & Current Investments over 5 years: stood at $170.8 million in 2022, then surged by 72.73% to $295.1 million in 2023, then sank by 32.91% to $198.0 million in 2024, then decreased by 13.46% to $171.3 million in 2025, then retreated by 21.44% to $134.6 million in 2026.
- Per Business Quant, the three latest MNKD Cash & Current Investments figures stand at $134.6 million (Q1 2026), $171.3 million (Q4 2025), and $260.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 2.13 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 32.30 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 286.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 61.46 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 2.77 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3.01 Bn |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn | 134.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 134.61 Mn |
| Dec 31, 2025 | 171.35 Mn |
| Sep 30, 2025 | 260.04 Mn |
| Jun 30, 2025 | 178.99 Mn |
| Mar 31, 2025 | 182.28 Mn |
| Dec 31, 2024 | 197.99 Mn |
| Sep 30, 2024 | 252.32 Mn |
| Jun 30, 2024 | 248.49 Mn |
| Mar 31, 2024 | 300.73 Mn |
| Dec 31, 2023 | 295.10 Mn |
| Sep 30, 2023 | 141.02 Mn |
| Jun 30, 2023 | 144.35 Mn |
| Mar 31, 2023 | 166.14 Mn |
| Dec 31, 2022 | 170.85 Mn |
| Sep 30, 2022 | 165.05 Mn |
| Jun 30, 2022 | 154.15 Mn |
| Mar 31, 2022 | 162.40 Mn |
| Dec 31, 2021 | 204.12 Mn |
| Sep 30, 2021 | 139.01 Mn |
| Jun 30, 2021 | 162.47 Mn |
| Mar 31, 2021 | 276.83 Mn |
| Dec 31, 2020 | 67.16 Mn |
| Sep 30, 2020 | 52.71 Mn |
| Jun 30, 2020 | 63.54 Mn |
| Mar 31, 2020 | 38.87 Mn |
| Dec 31, 2019 | 49.91 Mn |
| Sep 30, 2019 | 50.06 Mn |
| Jun 30, 2019 | 13.28 Mn |
| Mar 31, 2019 | 59.29 Mn |
| Dec 31, 2018 | 71.68 Mn |
| Sep 30, 2018 | 10.97 Mn |
| Jun 30, 2018 | 26.71 Mn |
| Mar 31, 2018 | 27.23 Mn |
| Dec 31, 2017 | 48.36 Mn |
| Sep 30, 2017 | 10.00 Mn |
| Jun 30, 2017 | 43.38 Mn |
| Mar 31, 2017 | 47.98 Mn |
| Dec 31, 2016 | 22.90 Mn |
| Sep 30, 2016 | 35.53 Mn |
| Jun 30, 2016 | 63.73 Mn |
| Mar 31, 2016 | 27.65 Mn |
| Dec 31, 2015 | 59.07 Mn |
| Sep 30, 2015 | 32.93 Mn |
| Jun 30, 2015 | 107.19 Mn |
| Mar 31, 2015 | 120.84 Mn |
| Dec 31, 2014 | 120.84 Mn |
| Sep 30, 2014 | 172.47 Mn |
| Jun 30, 2014 | 41.21 Mn |
| Mar 31, 2014 | 35.76 Mn |
| Dec 31, 2013 | 70.79 Mn |
| Sep 30, 2013 | 93.80 Mn |
| Jun 30, 2013 | 28.53 Mn |
| Mar 31, 2013 | 28.01 Mn |
| Dec 31, 2012 | 61.84 Mn |
| Sep 30, 2012 | 2.12 Mn |
| Jun 30, 2012 | 31.99 Mn |
| Mar 31, 2012 | 56.71 Mn |
| Dec 31, 2011 | 3.20 Mn |
| Sep 30, 2011 | 23.30 Mn |
| Jun 30, 2011 | 25.27 Mn |
| Mar 31, 2011 | 46.91 Mn |
| Dec 31, 2010 | 70.43 Mn |
| Sep 30, 2010 | 97.93 Mn |
| Jun 30, 2010 | 28.36 Mn |